The US Food and Drug Administration (FDA) has given permission for a dual-hormone artificial pancreas, dubbed the bionic pancreas, to be used in the homes of people with type 1 diabetes.
It is thought the pioneering iLet device could revolutionise diabetes treatment as it mimics the way a pancreas works, delivering insulin, glucagon or a combination. However, in the trial which has been given approval, the device will deliver just insulin.
The iLet has been developed by Edward Damiano, PhD, president of Boston-based Beta Bionics, who is aiming to have the device fully approved by official bodies in the foreseeable future. He introduced it to the world in 2015, calling it a “bridge to a cure” for type 1 diabetes.
The FDA has now given the go ahead for home-use clinical studies… Continue reading.
WASHINGTON, D.C.— The American Institute for Medical and Biological Engineering (AIMBE) has announced the pending induction of Edward R. Damiano, Ph.D., Professor of Biomedical Engineering, Department of Biomedical Engineering, Boston University, to its College of Fellows. Dr. Damiano was nominated, reviewed, and elected by peers and members of the College of Fellows For fundamental contributions in our understanding of microcirculation, and for designing, building, and testing a wearable bionic pancreas.